Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1970 Mar;1(3):271–273. doi: 10.1128/iai.1.3.271-273.1970

Protection of Mice Against Bacterial Infection by Interferon Inducers

Frank F Pindak 1
PMCID: PMC415891  PMID: 16557727

Abstract

Antibacterial effect of known interferon inducers was investigated. Intraperitoneal injection of statolon or pyran markedly enhanced the survival of mice challenged with Klebsiella pneumoniae. The sparing effect of these two interferon inducers resembled that of bacterial endotoxin. Significant protection was obtained when the inducers were administered 24 hr before challenge. Treatments given 6 hr before or at the time of infection were ineffective. The persistence of increased resistance of treated animals to encephalomyocarditis virus strain MM, inoculated 5 days after challenge with K. pneumoniae, indicated that the bacterial infection did not adversely influence the induction or effectiveness of interferon.

Full text

PDF
271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DUBOS R. J., SCHAEDLER R. W. Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J Exp Med. 1956 Jul 1;104(1):53–65. doi: 10.1084/jem.104.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hanna L., Merigan T. C., Jawetz E. Inhibition of TRIC agents by virus-induced interferon. Proc Soc Exp Biol Med. 1966 Jun;122(2):417–421. doi: 10.3181/00379727-122-31150. [DOI] [PubMed] [Google Scholar]
  3. Jahiel R. I., Nussenzweig R. S., Vanderberg J., Vilcek J. Anti-malarial effect of interferon inducers at different stages of development of Plasmodium berghei in the mouse. Nature. 1968 Nov 16;220(5168):710–711. doi: 10.1038/220710a0. [DOI] [PubMed] [Google Scholar]
  4. Jahiel R. I., Vilcek J., Nussenzweig R., Vanderberg J. Interferon inducers protect mice against plasmodium berghei malaria. Science. 1968 Aug 23;161(3843):802–804. doi: 10.1126/science.161.3843.802. [DOI] [PubMed] [Google Scholar]
  5. Kleinschmidt W. J., Murphy E. B. Interferon induction with statolon in the intact animal. Bacteriol Rev. 1967 Jun;31(2):132–137. doi: 10.1128/br.31.2.132-137.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kleinschmidt W. J., Murphy E. B. Investigations on interferon induced by statolon. Virology. 1965 Dec;27(4):484–489. doi: 10.1016/0042-6822(65)90173-x. [DOI] [PubMed] [Google Scholar]
  7. LANDY M., PILLEMER L. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Sep 1;104(3):383–409. doi: 10.1084/jem.104.3.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marcus P. I., Salb J. M. Molecular basis of interferon action: inhibition of viral RNA translation. Virology. 1966 Nov;30(3):502–516. doi: 10.1016/0042-6822(66)90126-7. [DOI] [PubMed] [Google Scholar]
  9. Merigan T. C., Finkelstein M. S. Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers. Virology. 1968 Jul;35(3):363–374. doi: 10.1016/0042-6822(68)90215-8. [DOI] [PubMed] [Google Scholar]
  10. Merigan T. C. Induction of circulating interferon by synthetic anionic polymers of known composition. Nature. 1967 Apr 22;214(5086):416–417. doi: 10.1038/214416a0. [DOI] [PubMed] [Google Scholar]
  11. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  12. Pindak F. F., Schmidt J. P. Propagation of MM virus in continuous cell lines. Appl Microbiol. 1969 Jun;17(6):815–818. doi: 10.1128/am.17.6.815-818.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. ROWLEY D. Rapidly induced changes in the level of non-specific immunity in laboratory animals. Br J Exp Pathol. 1956 Jun;37(3):223–234. [PMC free article] [PubMed] [Google Scholar]
  14. ROWLEY D. Stimulation of natural immunity to Escherichia coli infection: observations on mice. Lancet. 1955 Jan 29;268(6857):232–234. doi: 10.1016/s0140-6736(55)90163-x. [DOI] [PubMed] [Google Scholar]
  15. Remington J. S., Merigan T. C. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science. 1968 Aug 23;161(3843):804–806. doi: 10.1126/science.161.3843.804. [DOI] [PubMed] [Google Scholar]
  16. Sueltenfuss E. A., Pollard M. Cytochemical Assay of Interferon Produced by Duck Hepatitis Virus. Science. 1963 Feb 15;139(3555):595–596. doi: 10.1126/science.139.3555.595. [DOI] [PubMed] [Google Scholar]
  17. Youngner J. S., Stinebring W. R. Comparison of interferon production in mice by bacterial endotoxin and statolon. Virology. 1966 Jun;29(2):310–316. doi: 10.1016/0042-6822(66)90038-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES